Navigation Links
SpineSmith Adds Talented Scientist to Research and Development Team
Date:1/17/2012

AUSTIN, Texas, Jan. 17, 2012 /PRNewswire/ -- SpineSmith, a Celling Biosciences company that designs, develops and markets innovative technologies in the field of regenerative medicine, is pleased to announce the addition of Dr. Matthew Murphy to its team of PhDs.

Dr. Murphy joins SpineSmith in the position of Senior Scientist and will design and implement new strategies for the isolation and application of autologous stem cells for spine, orthopedics, and cardiovascular therapies.

"We are very happy to have Dr. Murphy join our team of PhDs. His expertise in biomaterials and cell technology brings SpineSmith an important opportunity to expand our research especially as we continue to grow as a company," said Vice President of Cell Therapies, Dr. Ted Sand.

Previously, Murphy was a senior researcher at Methodist Hospital Research Institute in Houston, Texas, where he focused on the combination of adult stem cells and biomaterials for regenerative medical applications in orthopedics, spine, pancreatic, and soft tissue repair.

Murphy holds a PhD in Bioengineering from Rice University and a B.S. in Chemical Engineering from The University of Texas at Austin. At Rice, he researched novel biomaterials for bone and cartilage regeneration and developed targeted drug delivery strategies. He also worked at NASA on the design of new spacesuits for travel to the moon and Mars as part of the Constellation Program.

He then joined the laboratory of Dr. Paul Simmons at UT Health Science Center at Houston where he investigated adult stem cells harvested from bone marrow, cortical bone, and adipose tissues. He has authored twelve peer-reviewed publications and two textbook chapters related to tissue engineering and drug delivery.

"I'm excited to help expand Celling Biosciences' therapeutic treatments using adult stem cells," said Dr. Murphy. "Using optimized biomaterials, natural enhancers such as PRP and extracellular matrix proteins, and effective delivery systems, we can maximize stem cell retention and bioactivity. Regenerative therapies are the future and a key to personalized medicine."

About SpineSmith LLC- A Celling Biosciences Company

SpineSmith Partners LP designs, develops and markets implants and biologics for surgical fixation, correction and tissue regeneration of the spine. SpineSmith utilizes a collaborative approach between scientists, engineers and spine surgeons. Our unique approach gives spine surgeons the ability to directly impact the direction of our product portfolio, ensuring applicability and achieving the highest standards of patient care.  For more information please visit:  www.spinesmithusa.com.  

 

 


'/>"/>
SOURCE SpineSmith LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SpineSmith Successful in VisuALIF Alpha Launch
2. Pioneer® Surgical Technology, Inc. Announces Agreement to Acquire Exclusive Access to the Cequence™ Cervical Plate System From SpineSmith, LP
3. SpineSmith Partners Announces FDA Clearance and Product Launch of VisuALIF Interbody Fusion Device at North American Spine Society Annual Meeting
4. SpineSmith Partners and Celling Technologies Hire New VP of Research and Development
5. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
6. New AquaLab Vapor Sorption Analyzer Puts Isotherm Technology Within Financial Reach of Food and Pharmaceutical Scientists
7. Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects
8. No European Scientists Left by 2020?
9. Life Technologies Makes Fluorescence Microscopy Accessible to All Scientists
10. American Skin Association Honors Leading Physicians and Scientists; Journalist Deborah Norville
11. Over 400 Graduate Level Scientists to Attend Virtual Job Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  A new genetic test has been ... individuals who carry HLA-B*15:02 and who ... potentially deadly side effect of certain medications used ... HLA-B*15:02 is strongly associated with life-threatening ... and toxic epidermal necrolysis in patients treated with ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... devices market exhibits a consolidated vendor landscape with the ... the overall market in 2015. These companies are ... Industries, Inc., Hygia Health Services, Inc., and VANGUARD ... global reprocessed medical devices market is witnessing the ...
(Date:3/23/2017)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... it has acquired Agalimmune Ltd., a private UK-based company with ... $6 million upfront payment, of which $3 million is in ... may be made based on development and commercial milestones. ... Agalimmune,s lead ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... 23, 2017 , ... The Wound Certification Prep Course ... Holdings, LLC, today announced that RestorixHealth® has officially endorsed WCPC as ... interested in becoming Certified Wound Specialist Physicians (CWSP®). , This collaborative effort ...
(Date:3/23/2017)... ... 23, 2017 , ... Altec Products, Inc. , a ... their 2016 Microsoft Dynamics Partner of the Year at DocLink Evolution , ... recognizes The Resource Group for their outstanding relationship with Altec and their ability ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The ... facing life-altering and fatal diseases in opposition to the President’s Fiscal Year ... eviscerate care, services, and hope for the most vulnerable among us. , The ...
(Date:3/23/2017)... Marina del Rey, CA (PRWEB) , ... March ... ... version of its customizable coding audit software solution, iCode Assurance, at HCCA’s 21st ... iCode Assurance optimizes and accelerates the coding audit process for all medical chart ...
Breaking Medicine News(10 mins):